Short sellers are moving fast this week. The biggest story is REPL — Replimune Group's SI % of Free Float jumped 10.75 points in just seven days to 38.1%. That's a sharp new bet against the oncology biotech.
WOLF — Wolfspeed — keeps absorbing fresh shorts too. SI % FF climbed another 6.3 points to 85.6%. Zero shares are available to borrow. Bears are already piled in and there's no room for new entrants.
HTZ sits at 64.1% SI % FF with a 12.1% cost to borrow and zero availability. Hertz remains a magnet for short sellers, off 59% in three months.
On the flip side, CHWY saw the biggest squeeze-like move. Short interest dropped 12.3 points to 63.4% over the week — still heavily shorted, but the cover is real. Availability is sky-high at 581%.
SPCX — the SpaceX listing — saw shorts cut by nearly to 19.8%. That's a notable retreat from one of the more talked-about names on social media.
C4 Therapeutics also drew new attention, with SI % FF rising 8.9 points to 31.7% — a significant jump for a small-cap drug developer.
Market backdrop is choppy. Iran tensions sent the Dow down 250 points today, and RTX just landed a $22.9B Tomahawk deal, keeping defence names in focus.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
